期刊文献+

预激方案治疗10例急性髓细胞性白血病的近期疗效观察

下载PDF
导出
摘要 目的观察预激方案治疗急性髓细胞白血病的疗效。方法10例急性髓细胞白血病患者采用预激方案治疗,其中有6名患者曾接受过MA、DA方案诱导无效而接受预激方案治疗,3例为治疗相关性白血病患者,3例为复发患者。结果10例中有8例达完全缓解,缓解率达80%。结论预激方案对急性髓细胞白血病有较好的疗效,特别是对难治的、复发的和/或治疗相关性的白血病治疗效果相对较好,且毒副反应可耐受,值得进一步研究及推广应用。
作者 陈为民
出处 《中国现代医药杂志》 2006年第11期41-42,共2页 Modern Medicine Journal of China
  • 相关文献

参考文献3

二级参考文献11

  • 1全国白血病化学治疗讨论会.急性白血病疗效标准[J].中华血液学杂志,1988,9(3):183-183.
  • 2Hiddemann W, Martin WR, Sauerland CM,et al. Definition of refractoriness against conventional chemotherapy in acute myeloid leukemia: a proposal based on the results of retreatment by thioguanine, cytosine arabinoside, and daunorubiein (TAD 9) in 150 patients with relapse after standardized first line therapy.Leukemia, 1990, 4: 184-188.
  • 3Yamada K, Furusawa S, Saito K, et al. Concurrent use of granulocyte colony-stimulating factor with low-dose cytosine arabinoside and aelarubiein for previously treated acute myelngenous leukemia: a pilot study. Leukemia, 1995, 9: 10-14.
  • 4Saito K, Nakamura Y, Aoyagi M, et al. Low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) for previously treated patients with relapsed or primary resistant acute myelogenous leukemia (AML)and previously untreated elderly patients with AML, secondary AML, and refractory anemia with excess blasts in transformation. Int J Hematol, 2000. 71: 238-244.
  • 5Park LS, Waldron PE, Friend D, et al. Interleukin-3, GM-CSF and G-CSF receptor expression on cell lines and primary leukemia cells: receptor heterogeneity and relationship to growth factor responsiveness. Blood, 1989, 74: 56-65.
  • 6Wormann B, Reuter C, Zuhlsdorf M, et al. Experimental basis for the use of recombinant human granulocyte-maerophage colonystimulating factor in patients with acute myeloid leukemia. Semin Oncol, 1994, 21(6 suppl 16) : 39-43.
  • 7Bai A, Kojima H, Hori M, et al. Priming with G-CSF effectively enhances low-dose Ara-C-indueed in vivo apoptosis in myeloid leukemia cells. Exp Hematol, 1999, 27: 259-265.
  • 8Katagiri T, Miyazawa K, Nishimaki J, et al. Combination of granulocyte colony-stimulating factor and low-dose cytosine arabinoside further enhances myeloid differentiation in leukemia cells in vitro. Leuk Lymphoma, 2000, 39: 173-184.
  • 9Hasegawa Y, Bai A, Kojima H, et al. Priming effects of macrophage colony-stimulating factor on monocytic leukemia cells in combination with chemotherapy: induction of programmed cell death in vivo. Leuk Lymphoma, 2000, 36: 589-593.
  • 10Akashi K, Eto T, Shibuya T, et al. Aclarubicin induces differentiation of leukemic progenitors in myelodysplastic syndrome cooperating with granulocyte colony-stimulating factor. Leuk Res,2000, 24:243-248.

共引文献134

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部